Fig. 1.
Cohort diagram; 103 patients receiving immune checkpoint inhibitor (ICI) therapy met laboratory thresholds for grade 2 immune related hepatitis (irH) and had an accompanying provider documented diagnosis of irH; 97 cases were included in the analysis and matched with controls based on age, sex, time of ICI initiation and length of follow-up. ECOG Eastern Cooperative Oncology Group